Replacement | Medicines | 15/07/2011

The marketing authorization holder informed its supplied customers in a letter dated July 7, 2011, that another batch that had exceeded the 18-month shelf life would be replaced. Already on April 12, 2011, batches were withdrawn from the market after it had to be determined that the occurrence of visible particles is possible if the runtime of 18 months is exceeded.

Name of the medicinal product Lasix 250 mg - Konzentrat zur Infusion
Marketing authorisation number(s) 15.861
Marketing authorisation holder Sanofi-aventis GmbH
Batch number(s) 0F001A
Classification of the recallI
BASG reference number INS-640.001-0096

Further inquiry note